Just got pinged:
Leerink out VERY positive again ..We believe HGSI is poised to become the next large cap biotech... GILD had the same market cap in January 2000. Since then, the clear winner has been GILD as it became the second largest biotechnology company. GILD attained this status by cornering the HIV market in a manner similar to how HGSI could now potentially corner the lupus and other markets...
We believe an acquisition could be the greatest impediment to HGSI becoming the next big biotech. If GSK performs an analysis similar to that outlined above, we believe they will realize the incremental 50% rights to Benlysta is likely worth much more than HGSI's ~$2B market cap...Reits Outperform and $30 tgt.
Notablecalls: Stock should fly on this!
Leerink out VERY positive again ..We believe HGSI is poised to become the next large cap biotech... GILD had the same market cap in January 2000. Since then, the clear winner has been GILD as it became the second largest biotechnology company. GILD attained this status by cornering the HIV market in a manner similar to how HGSI could now potentially corner the lupus and other markets...
We believe an acquisition could be the greatest impediment to HGSI becoming the next big biotech. If GSK performs an analysis similar to that outlined above, we believe they will realize the incremental 50% rights to Benlysta is likely worth much more than HGSI's ~$2B market cap...Reits Outperform and $30 tgt.
Notablecalls: Stock should fly on this!
No comments:
Post a Comment